Related Experiment Video

Updated: Dec 21, 2025

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
13:07

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

4.3K

Cardiovascular Disease Prevention and Implications of Coronavirus Disease 2019: An Evolving Case Study in the

Alexander C Razavi1,2, Tanika N Kelly1, Jiang He1,2

  • 1Department of Epidemiology Tulane University School of Public Health and Tropical Medicine New Orleans LA.

Journal of the American Heart Association
|May 19, 2020
PubMed

Insights

The COVID-19 pandemic disproportionately impacts cardiovascular disease (CVD) patients, especially in Louisiana. This review examines CVD prevention strategies amidst the pandemic, focusing on New Orleans and racial disparities.

Area of Science:

  • Public Health
  • Cardiovascular Medicine
  • Epidemiology

Background:

  • Traditionally, communicable and noncommunicable disease management are separate, but COVID-19 has blurred these lines, particularly for cardiovascular disease (CVD).
  • Individuals with pre-existing CVD face a significantly higher risk of mortality from COVID-19.
  • Louisiana exhibits poor cardiovascular health rankings and high COVID-19 case-fatality rates, highlighting a critical public health issue.

Purpose of the Study:

  • To review cardiovascular disease (CVD) prevention and COVID-19 implications in New Orleans, LA.
  • To analyze the pandemic's impact on healthcare access, pharmacotherapy, and lifestyle behaviors affecting CVD.
  • To identify strategies for improving CVD prevention amidst the COVID-19 pandemic and future crises.

Main Methods:

  • Review of existing literature and public health data.
  • Analysis of the intersection between cardiovascular disease and COVID-19 in a specific urban setting.
  • Examination of potential pandemic-driven changes in healthcare access and patient behaviors.

Main Results:

  • The COVID-19 pandemic has exacerbated existing disparities in cardiovascular health.
  • Pandemic-related disruptions may negatively impact CVD prevention and management, particularly for vulnerable populations.
  • Racial disparities in both CVD and COVID-19 outcomes are a significant concern.

Conclusions:

  • Urgent public health interventions are needed to address the compounded effects of COVID-19 and CVD.
  • Recommendations focus on enhancing CVD prevention strategies within the context of the pandemic.
  • Improving healthcare access and addressing lifestyle factors are crucial for mitigating disparities and improving outcomes.

Keywords:
COVID‐19cardiovascular diseasecoronavirusdietprimary preventionquarantinerace

More Related Videos

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.9K
Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic09:03

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic

Published on: November 7, 2020

5.3K

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
528
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
779
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
173
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
281
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
239
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
161